(Q39095849)

9 September 2017

title

Metabolic alterations during the growth of tumour spheroids (English)

1 reference

9 September 2017

4

1 reference

9 September 2017

Richard Callaghan

8

0 references

Hannah Brenkert-Smith

2

object named as

Hannah Smith

1 reference

9 September 2017

7

Philip Maini

1 reference

9 September 2017

Katarzyna Bloch

1

1 reference

9 September 2017

Victoria van Hamel Parsons

3

1 reference

9 September 2017

Catherine Kelly

5

1 reference

9 September 2017

Alexander Fletcher

6

1 reference

9 September 2017

publication date

1 April 2014

1 reference

Cell Biochemistry and Biophysics

9 September 2017

published in

1 reference

9 September 2017

volume

68

1 reference

9 September 2017

issue

3

1 reference

9 September 2017

page(s)

615-628

1 reference

https://scigraph.springernature.com/pub.10.1007/s12013-013-9757-7

9 September 2017

exact match

0 references

cites work

On the Origin of Cancer Cells

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Metabolic reprogramming: a cancer hallmark even warburg did not anticipate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Mitochondriotoxic compounds for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Energy metabolism in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Glucose utilization in vivo by human pulmonary neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

The metabolic advantage of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

MYC-induced cancer cell energy metabolism and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Glutaminolysis: supplying carbon or nitrogen or both for cancer cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Regulation of cancer cell metabolism by hypoxia-inducible factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

TIGAR, a p53-inducible regulator of glycolysis and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

The role of carbonic anhydrase 9 in regulating extracellular and intracellular ph in three-dimensional tumor cell growths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Diffusivity and distribution of vinblastine in three-dimensional tumour tissue: experimental and mathematical modelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Comparative efficacy of novel platinum(IV) compounds with established chemotherapeutic drugs in solid tumour models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Multicellular tumor spheroids: an underestimated tool is catching up again.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Regulation of hexokinase binding to VDAC

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Pore protein and the hexokinase-binding protein from the outer membrane of rat liver mitochondria are identical

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Reversible high affinity inhibition of phosphofructokinase-1 by acyl-CoA: a mechanism integrating glycolytic flux with lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Fructose 2,6-bisphosphate 2 years after its discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Control of glycolysis through regulation of PFK1: old friends and recent additions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Two ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-beta-TrCP, sequentially regulate glycolysis during the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Structural and biochemical studies of TIGAR (TP53-induced glycolysis and apoptosis regulator)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Pyruvate kinase M2 is a phosphotyrosine-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Physiological functions of the pentose phosphate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Glucose-6-phosphate dehydrogenase, NADPH, and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Regulation of pentose phosphate pathway dehydrogenases by NADP+/NADPH ratios

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Renal cell carcinoma and oxidative stress: The lack of peroxisomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Three-dimensional cell culture induces novel proliferative and metabolic alterations associated with oncogenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

Energy metabolism transition in multi-cellular human tumor spheroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-013-9757-7

10.1007/S12013-013-9757-7

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference